Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCA| |CCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGA
End
33315487/33315381 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/920906; hsa-mir-103a-1/Downstream/2832511;
Upstream sequence
ATAGTCTTTAATTCTGCCCTGTTTCCCACCATGTCCATCCTTTTCTATGCTAAGTCATAATGTTTCCACATAGAATCCTTTGAAATTTACTATCCTGTTT
Downstream sequence
CAAATAACTGGATAAAAGTACATAGTTAGATGATGCAGAATGTGTGTATGCCTGGACTAAACCAGGCCTCTAGCCAGATGATTAGCCACATCGAAAAATT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.